These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Effectiveness of synthetic calcitonin derivative (elcatonin) on the bone pain and serum calcium concentration in multiple myeloma]. Hirota Y; Kondou S; Okamura H; Ikematsu W; Aso T; Kounoue E; Matsumoto I; Kuwashima K; Kajiyama K Gan To Kagaku Ryoho; 1990 May; 17(5):1059-63. PubMed ID: 2334172 [TBL] [Abstract][Full Text] [Related]
6. Chemotherapy did not enhance the anti-osteolytic effects of bisphosphonate in multiple myeloma bone disease. Ogata A; Kitano M; Hashimoto N; Iwasaki T; Hamano T; Kakishita E J Bone Miner Metab; 2002; 20(4):240-2. PubMed ID: 12115071 [No Abstract] [Full Text] [Related]
8. [Plasmacytoma and support therapy with calcitonin]. Adam Z Vnitr Lek; 1991; 37(11-12):898-900. PubMed ID: 1796564 [TBL] [Abstract][Full Text] [Related]
9. [Bone diseases with Pain. Osteoporosis]. Hayashi Y Clin Calcium; 2007 Apr; 17(4):606-12. PubMed ID: 17404492 [TBL] [Abstract][Full Text] [Related]
10. Safety and pain palliation of zoledronic acid in patients with breast cancer, prostate cancer, or multiple myeloma who previously received bisphosphonate therapy. Vogel CL; Yanagihara RH; Wood AJ; Schnell FM; Henderson C; Kaplan BH; Purdy MH; Orlowski R; Decker JL; Lacerna L; Hohneker JA Oncologist; 2004; 9(6):687-95. PubMed ID: 15561812 [TBL] [Abstract][Full Text] [Related]
11. Supportive care in myeloma. Berenson JR Clin Adv Hematol Oncol; 2004 Sep; 2(9):569, 571. PubMed ID: 16163246 [No Abstract] [Full Text] [Related]
12. [Bone manifestations of multiple myeloma and therapeutic possibilities]. Adam Z; Vorlícek J Acta Med Austriaca; 1994; 21(5):117-21. PubMed ID: 7709707 [TBL] [Abstract][Full Text] [Related]
13. [Biphosphonates and multiple myeloma]. Mazières B; Laroche M; Cantagrel A Bull Cancer; 1993; 80(10 Suppl):45-9. PubMed ID: 8081030 [No Abstract] [Full Text] [Related]
16. Strategies in treating newly diagnosed or untreated multiple myeloma patients. From the Multiple Myeloma Research Foundation. Weber DM Oncology (Williston Park); 2003 Jun; 17(6):765-7. PubMed ID: 12846120 [TBL] [Abstract][Full Text] [Related]
17. Supportive care in multiple myeloma. Ludwig H; Zojer N Best Pract Res Clin Haematol; 2007 Dec; 20(4):817-35. PubMed ID: 18070721 [TBL] [Abstract][Full Text] [Related]
18. How can we improve the treatment of bone metastases further? Coleman RE Curr Opin Oncol; 1998 Aug; 10 Suppl 1():S7-13. PubMed ID: 9801853 [TBL] [Abstract][Full Text] [Related]
19. [The complications during the therapy for multiple myeloma]. Spicka I Vnitr Lek; 2006 Feb; 52(2):115. PubMed ID: 16623271 [No Abstract] [Full Text] [Related]
20. Multiple myeloma: primary bone tumor with systemic manifestations. Bilsky MH; Azeem S Neurosurg Clin N Am; 2008 Jan; 19(1):31-40. PubMed ID: 18156045 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]